Standard Generalized Markup Language: Ready for Canda and beyond

Abstract

This paper provides a new look at standard generalized markup language (SGML), a technology whose benefits include reuse of information and the potential for reducing costs in managing information. The impediments of the early SGML have significantly abated, yet the shift to SGML will not come smoothly or without effort. While CANDA and other regulatory submissions may be the reason for drug companies to implement SGML, installing it enterprise-wide makes sense and will achieve other corporate objectives, including internal efficiencies with regard to document handling.